David Gardner

Vertrieb & Marketing bei

iShares Plc

Finance

Miscellaneous

Health Technology

Profil

David Gardner is currently the Head-EMEA Sales at iShares Plc.
Prior to this, he worked as a Director at Xilio Therapeutics, Inc. in 2021.
He also worked as an Analyst at BlackRock Advisors LLC from 2009 to 2011.

Aktive Positionen von David Gardner

Unternehmen	Position	Beginn
iShares Plc iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund	Vertrieb & Marketing	20.10.2011

Alle aktiven Positionen von David Gardner

Ehemalige bekannte Positionen von David Gardner

Unternehmen	Position	Ende
XILIO THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	01.10.2021
BlackRock Advisors LLC BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies.	Analyst-Equity	09.09.2011

Sehen Sie sich die Erfahrung von David Gardner im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Gardner im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	3
BlackRock Advisors LLC BlackRock Advisors LLC Investment ManagersFinance BlackRock Advisors offers investors around the world a variety of investment products that span across asset classes, market-caps, investment styles and geographic regions. Their mandates include cash management, equity, fixed income, alternative, multi-asset and quantitative equity strategies.	Finance
iShares Plc iShares Plc Investment Trusts/Mutual FundsMiscellaneous Exchange Traded Fund	Miscellaneous
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology